09:01

PBPK modelling: A potential area of research for M.Phill & Ph.D. students

10:00

Pharmacokinetics of alcohol A drug that follows zero order kinetics

17:28

New-Mental health of research/PhD students

00:07

mental health of research studnets

15:20

My thoughts on pharmacy

27:08

Health accessories II

25:03

Health accessories I

23:48

Intravenous infusions 4 Clinical significance

22:41

Intravenous infusions 3 steady state level

26:31

Intravenous infusions 2

25:52

Intravenous infusions

25:25

Impact of hepatic impairment on pharmacokinetics

22:49

Variation in Pharmacokinetics in disease states

26:41

Drug product considerations in developing a dosage form 1

25:06

Formulation considerations in developing a dosage form

25:15

Drug considerations in developing a dosage form

17:19

Biopharmaceutical considerations in developing a dosage form

24:28

Distribution of drugs

16:41

Factors to consider for IVIVC studies

16:45

Introduction to IVIVC and its various levels

19:55

inventory control of drugs

16:48

Effect of protein binding on pharmacokinetics

20:18

Purchase of drugs

17:29

types of binding proteins

13:17

Nuclear Pharmacy II

15:08

Introduction to Protein binding

13:40

Nuclear Pharmacy

15:27

Report format of bioequivalence studies

14:28

Protocol of bioavailability studies II,

10:45

TPN or hyperalimentation

15:57

bioavailability and bioequivalence protocol of bioavailability studies

10:09

bioavailability and bioequivalenceTypes of bioavailability

12:00

BIOAVAILABILITY & BIOEQUIVALENCE

06:57

Protein binding 4-Effect of plasma protein binding on volume of distribution-clinical significance

06:59

Protein Binding 3

06:20

Protein binding 2- Types of Plasma Proteins

05:26

Protein binding 1